Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells

Fei Shen, Shaoyou Chu, Aimee K. Bence, Barbara Bailey, Xinjian Xue, Priscilla A. Erickson, Marshall H. Montrose, William T. Beck, Leonard C. Erickson

Research output: Contribution to journalArticle

200 Citations (Scopus)

Abstract

P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The MDR cells were approximately 9-fold more resistant to the anticancer drug doxorubicin than their parental wild-type MDA-MB-435wt (WT) cells. Doxorubicin accumulation in the MDR cells was only 19% of that in the WT cells. The net uptake of doxorubicin in the nuclei of the MDR cells was 2-fold lower than that in the nuclei of the WT cells. Pgp inhibitors verapamil, cyclosporine A, or PSC833 increased doxorubicin accumulation in the MDR cells up to 79%, and it reversed drug resistance in these cells. In living animals, doxorubicin accumulation in MDA-MB-435mdr xenograft tumors was 68% of that in the wild-type tumors. Administration of verapamil, cyclosporine A, or PSC833 before doxorubicin treatment of the animals increased doxorubicin accumulation in the MDR tumors up to 94%. These studies have added direct in vitro and in vivo information on the capacity of the transporter protein Pgp to efflux doxorubicin and on the reversal of MDR by Pgp inhibitors in resistant cancer cells.

Original languageEnglish
Pages (from-to)95-102
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume324
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Multiple Drug Resistance
Doxorubicin
P-Glycoprotein
Neoplasms
Verapamil
Cyclosporine
Pharmaceutical Preparations
Membrane Transport Proteins
Cell Nucleus
Drug Resistance
Heterografts
Confocal Microscopy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. / Shen, Fei; Chu, Shaoyou; Bence, Aimee K.; Bailey, Barbara; Xue, Xinjian; Erickson, Priscilla A.; Montrose, Marshall H.; Beck, William T.; Erickson, Leonard C.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 324, No. 1, 01.2008, p. 95-102.

Research output: Contribution to journalArticle

Shen, F, Chu, S, Bence, AK, Bailey, B, Xue, X, Erickson, PA, Montrose, MH, Beck, WT & Erickson, LC 2008, 'Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells', Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 1, pp. 95-102. https://doi.org/10.1124/jpet.107.127704
Shen, Fei ; Chu, Shaoyou ; Bence, Aimee K. ; Bailey, Barbara ; Xue, Xinjian ; Erickson, Priscilla A. ; Montrose, Marshall H. ; Beck, William T. ; Erickson, Leonard C. / Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells. In: Journal of Pharmacology and Experimental Therapeutics. 2008 ; Vol. 324, No. 1. pp. 95-102.
@article{76d624f36b914707b692f28f28d621b5,
title = "Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells",
abstract = "P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The MDR cells were approximately 9-fold more resistant to the anticancer drug doxorubicin than their parental wild-type MDA-MB-435wt (WT) cells. Doxorubicin accumulation in the MDR cells was only 19{\%} of that in the WT cells. The net uptake of doxorubicin in the nuclei of the MDR cells was 2-fold lower than that in the nuclei of the WT cells. Pgp inhibitors verapamil, cyclosporine A, or PSC833 increased doxorubicin accumulation in the MDR cells up to 79{\%}, and it reversed drug resistance in these cells. In living animals, doxorubicin accumulation in MDA-MB-435mdr xenograft tumors was 68{\%} of that in the wild-type tumors. Administration of verapamil, cyclosporine A, or PSC833 before doxorubicin treatment of the animals increased doxorubicin accumulation in the MDR tumors up to 94{\%}. These studies have added direct in vitro and in vivo information on the capacity of the transporter protein Pgp to efflux doxorubicin and on the reversal of MDR by Pgp inhibitors in resistant cancer cells.",
author = "Fei Shen and Shaoyou Chu and Bence, {Aimee K.} and Barbara Bailey and Xinjian Xue and Erickson, {Priscilla A.} and Montrose, {Marshall H.} and Beck, {William T.} and Erickson, {Leonard C.}",
year = "2008",
month = "1",
doi = "10.1124/jpet.107.127704",
language = "English",
volume = "324",
pages = "95--102",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells

AU - Shen, Fei

AU - Chu, Shaoyou

AU - Bence, Aimee K.

AU - Bailey, Barbara

AU - Xue, Xinjian

AU - Erickson, Priscilla A.

AU - Montrose, Marshall H.

AU - Beck, William T.

AU - Erickson, Leonard C.

PY - 2008/1

Y1 - 2008/1

N2 - P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The MDR cells were approximately 9-fold more resistant to the anticancer drug doxorubicin than their parental wild-type MDA-MB-435wt (WT) cells. Doxorubicin accumulation in the MDR cells was only 19% of that in the WT cells. The net uptake of doxorubicin in the nuclei of the MDR cells was 2-fold lower than that in the nuclei of the WT cells. Pgp inhibitors verapamil, cyclosporine A, or PSC833 increased doxorubicin accumulation in the MDR cells up to 79%, and it reversed drug resistance in these cells. In living animals, doxorubicin accumulation in MDA-MB-435mdr xenograft tumors was 68% of that in the wild-type tumors. Administration of verapamil, cyclosporine A, or PSC833 before doxorubicin treatment of the animals increased doxorubicin accumulation in the MDR tumors up to 94%. These studies have added direct in vitro and in vivo information on the capacity of the transporter protein Pgp to efflux doxorubicin and on the reversal of MDR by Pgp inhibitors in resistant cancer cells.

AB - P-glycoprotein (Pgp), a membrane transporter encoded by the MDR1 gene in human cells, mediates drug efflux from cells, and it plays a major role in causing multidrug resistance (MDR). Confocal microscopy was used to study in vitro and in vivo drug accumulation, net uptake and efflux, and MDR modulation by P-glycoprotein inhibitors in MDR1-transduced human MDA-MB-435mdr (MDR) cancer cells. The MDR cells were approximately 9-fold more resistant to the anticancer drug doxorubicin than their parental wild-type MDA-MB-435wt (WT) cells. Doxorubicin accumulation in the MDR cells was only 19% of that in the WT cells. The net uptake of doxorubicin in the nuclei of the MDR cells was 2-fold lower than that in the nuclei of the WT cells. Pgp inhibitors verapamil, cyclosporine A, or PSC833 increased doxorubicin accumulation in the MDR cells up to 79%, and it reversed drug resistance in these cells. In living animals, doxorubicin accumulation in MDA-MB-435mdr xenograft tumors was 68% of that in the wild-type tumors. Administration of verapamil, cyclosporine A, or PSC833 before doxorubicin treatment of the animals increased doxorubicin accumulation in the MDR tumors up to 94%. These studies have added direct in vitro and in vivo information on the capacity of the transporter protein Pgp to efflux doxorubicin and on the reversal of MDR by Pgp inhibitors in resistant cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=37349069575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349069575&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.127704

DO - 10.1124/jpet.107.127704

M3 - Article

C2 - 17947497

AN - SCOPUS:37349069575

VL - 324

SP - 95

EP - 102

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -